Drugs / GC1107
GC1107
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01402713 | Aug 2011 → Nov 2013 | bacterial infectious disease | Green Cross Corporation | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02361866 | May → Sep 2014 | bacterial infectious disease | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GC1107 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01402713 ↗ |
| Known as | adult tetanus diphtheria [Td] vaccine | “GC1107 (adult tetanus diphtheria [Td] vaccine).” PMID 30686952 ↗ Jan 2019 |
| Known as | Adult Tetanus Diphtheria Vaccine | “GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.” PMID 30686952 ↗ Jan 2019 |
| Route | Intramuscular | “GC1107' Administered Intramuscularly” NCT01402713 ↗ |